RNA Virus Infections: Clinical Trials

21,344 trials for RNA Virus Infections, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

14290 completed, 3269 unknown, 1228 terminated, 821 recruiting. 4778 Not applicable, 4034 Phase 2, 3115 Phase 1, 2914 Phase 3, 1644 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable4778Completed 3202, Unknown 716, Recruiting 253, Terminated 179, Active not recruiting 136, Withdrawn 131, Not yet recruiting 117, Enrolling by invitation 31, Suspended 13
Phase 24034Completed 2633, Unknown 474, Terminated 429, Withdrawn 234, Recruiting 127, Active not recruiting 70, Not yet recruiting 47, Suspended 16, Enrolling by invitation 4
Phase 13115Completed 2400, Unknown 236, Terminated 184, Withdrawn 126, Recruiting 78, Active not recruiting 53, Not yet recruiting 33, Suspended 3, Enrolling by invitation 2
Phase 32914Completed 1979, Unknown 357, Terminated 252, Withdrawn 150, Recruiting 76, Active not recruiting 53, Not yet recruiting 29, Suspended 16, Enrolling by invitation 2
Phase 41644Completed 1102, Unknown 244, Terminated 136, Withdrawn 57, Recruiting 48, Active not recruiting 28, Not yet recruiting 20, Suspended 5, Enrolling by invitation 4
Early Phase 1114Completed 53, Unknown 32, Terminated 8, Withdrawn 6, Active not recruiting 5, Not yet recruiting 4, Recruiting 3, Suspended 3

Follow RNA Virus Infections: new trials by email Literature Review of RNA Virus Infections trials Research Report on RNA Virus Infections

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluating a Clinical Decision Support Tool for Antiretroviral Therapy Optimization
smART (Smart Antiretroviral Therapy Assistant), Traditional Prescribing resources - HIV (Human Immunodeficiency Virus), Clinical Decision Support System (CDSS)
Not applicableNot yet recruitingKeck School of Medicine of USC2502028-09-012025-10-22
Integrated Care Versus Usual Care for Opioid Use Disorder and Infectious Diseases in Veterans
Integrated care - Opioid Use Disorder, HIV
Not applicableNot yet recruitingVA Office of Research and Development602028-04-032026-04-24
Social Contact-Based Brief Video Interventions To Reduce Stigma and ImproVe Engagement in HIV Prevention and Care and Mental Health Care for Youth Living With and Vulnerable to HIV
Brief Videos for HIV Stigma - HIV, Mental Health
Not applicableNot yet recruitingCity University of New York, School of Public Health39002028-01-012026-10-01
Same-Day Antiretroviral Therapy as a Behavioral Design Intervention to Reduce Stigma in Key Affected Populations
SD-ART - Hiv
Not applicableNot yet recruitingYale University1392027-10-012026-08-31
Against Chikungunya Virus and Neonatal Infection
plasma transfusion : PC-CHIK-V - Chikungunya Virus Infection, Neonatal
Not applicableRecruitingCentre Hospitalier Universitaire de la Réunion602027-08-012026-09-15
Perceptions of Undergraduate Students and Teaching Staff on Online Teaching
Questionnaire - Covid19
SuspendedMisr International University92092027-07-152026-10-08
Scaling Up Implementation Strategies to Improve the DIAGNOSE and PREVENT Pillars for Young MSM in Florida
Workforce Development (WD) strategies, Quality Management (QM) and Mystery Shopper (MS) Feedback - Hiv
Not applicableNot yet recruitingFlorida State University812027-06-012026-10-13
HC-HMP: Healthy Choices Implementation Trial
Healthy Choices (HC), HealthMpowerment (HMP), Low-Touch: Video Introduction - Alcohol Drinking, HIV Infections
Not applicableNot yet recruitingFlorida State University3602027-06-012026-11-06
Phase III Clinical Trial of Hepalatide in Patients With Chronic Hepatitis D
Hepalatide 2.1mg, Placebo of Hepalatide - Hepatitis D, Chronic
Phase 3Not yet recruitingShanghai HEP Pharmaceutical Co., Ltd.1502027-06-012026-10-28
Advanced HIV Re-engagement in Care
ARC - Advanced HIV Disease
Not applicableNot yet recruitingUniversity of Alabama at Birmingham7242027-05-012026-07-23
STRIVES: Status-Neutral TeleHealth Concierge Intervention for Unhoused People Who Use Drugs Via Engagement Through Street Medicine
Standard of Care (Patient Navigation to Off-Site Clinic), Status-Neutral Telehealth Concierge (SN-THR) - HIV, Substance Use Disorder (SUD)
Not applicableNot yet recruitingUniversity of Miami2002027-05-012026-11-12
Integrated Health Services (IHS): A Structural Intervention to Improve HIV/STI Screening and PrEP Navigation in Primary Care
Integrated HIV/STI Testing and PrEP Navigation Model - HIV, STDs
Not applicableNot yet recruitingMy Brother's Keeper, Inc.7002027-05-012026-11-17
Incidence of HIV Infection in Screening Indian Men Who Have Sex With Men
Cytology Specimen Collection Procedure, Laboratory Biomarker Analysis, Medical Examination - HIV Infection
WithdrawnAIDS Malignancy Consortium2027-04-302025-06-06
Incidence of HPV Infection and HPV-Associated Disease in Screening Indian Men Who Have Sex With HIV-Positive Men
Cytology Specimen Collection Procedure, High Resolution Anoscopy with Biopsy, Laboratory Biomarker Analysis - HIV Infection, Human Papillomavirus Infection
WithdrawnAIDS Malignancy Consortium2027-04-302025-06-06
Telenursing-Based Sleep Coaching for Adults Living With HIV With Insomnia Symptoms
Telenursing-based sleep coaching - Insomnia, HIV Infections
Not applicableNot yet recruitingUniversitas Indonesia502027-04-012026-10-23
Integrating Supports to Promote PrEP for Black Adolescents Working With Apps- Atlanta
Health MPowerment App - HIV Infections
Not applicableNot yet recruitingEmory University102027-04-012026-09-22
PrEPwise Pilot Among Black Women in Eastern Virginia
PrEPwise, Usual care - HIV Infections, Sexually Transmitted Infection
Not applicableNot yet recruitingBoston University1082027-04-012026-02-11
PositiveLinks for Youth (PL4Y) for Texas
PositiveLinks for Youth Smartphone App - Human Immunodeficiency Virus, HIV
Not applicableNot yet recruitingThe University of Texas Health Science Center at San Antonio6002027-04-012026-09-04
Trial to Evaluate the Immunogenicity and Safety of the Co-administration of Live Attenuated Dengue and Chikungunya Vaccines Compared to Separate Administration in Adults Aged 18 to 59 Years.
DENGUE: Dengue 1,2,3,4 (attenuated) vaccine CHIKUNGUNYA: Chikungunya (CHIKV) live attenuated vaccine (VLA1555), DENGUE: Dengue 1,2,3,4 (attenuated) vaccine, Chikungunya (CHIKV) live attenuated vaccine (VLA1555) - Dengue, Chikungunya
Phase 3Not yet recruitingButantan Institute9002027-03-312026-07-16
Safety & Immunogenicity of 426c.Mod.Core-C4b Vaccine With 3M-052-AF+Alum in Infants Perinatally Exposed to HIV But Uninfected
426c.Mod.Core-C4b, 3M-052-AF, Aluminum hydroxide suspension (Alum) - HIV Infections
Phase 1Not yet recruitingHIV Vaccine Trials Network222027-03-302026-09-18

Showing 20 of 21344. Sign in to see all of them.

Narrower conditions

COVID-19 (7578)  ·  HIV Infections (4681)  ·  Acquired Immunodeficiency Syndrome (3039)  ·  Influenza, Human (2169)  ·  Hepatitis C (1722)  ·  Coronavirus Infections (1112)  ·  Hepatitis C, Chronic (907)  ·  Post-Acute COVID-19 Syndrome (601)  ·  Infections (373)  ·  Virus Diseases (366)  ·  Severe Acute Respiratory Syndrome (357)  ·  Respiratory Syncytial Virus Infections (304)  ·  AIDS-Related Complex (283)  ·  Dengue (275)  ·  Pneumonia (274)

Broader conditions

Virus Diseases (20978)  ·  Infections (20971)  ·  Respiratory Tract Diseases (10596)  ·  Respiratory Tract Infections (10326)  ·  Blood-Borne Infections (8963)  ·  Communicable Diseases (8947)  ·  Nidovirales Infections (8344)  ·  Coronaviridae Infections (8337)  ·  Lung Diseases (8247)  ·  Pneumonia, Viral (7876)  ·  Pneumonia (7859)  ·  Coronavirus Infections (7253)  ·  Immune System Diseases (7037)  ·  Urogenital Diseases (6964)

Interventions

Ribavirin (695)  ·  Influenza Vaccines (434)  ·  Ritonavir (409)  ·  peginterferon alfa-2a (322)  ·  Zidovudine (320)  ·  Standard of Care (293)  ·  Lamivudine (261)  ·  Tenofovir (221)  ·  efavirenz (217)  ·  Blood Specimen Collection (216)  ·  Lopinavir (182)  ·  Sofosbuvir (181)  ·  Hydroxychloroquine (180)  ·  Surveys and Questionnaires (167)  ·  peginterferon alfa-2b (164)

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID) (1439)  ·  GlaxoSmithKline (474)  ·  Merck Sharp & Dohme LLC (296)  ·  ViiV Healthcare (249)  ·  Sanofi Pasteur, a Sanofi Company (239)  ·  Gilead Sciences (218)  ·  Hoffmann-La Roche (179)  ·  Bristol-Myers Squibb (176)  ·  Pfizer (166)  ·  Assistance Publique - Hôpitaux de Paris (165)  ·  University of California, San Francisco (157)  ·  University of North Carolina, Chapel Hill (146)  ·  ANRS, Emerging Infectious Diseases (128)  ·  Assiut University (112)  ·  Columbia University (106)

Countries

United States (7816)  ·  France (1589)  ·  Spain (1022)  ·  China (1009)  ·  Canada (992)  ·  United Kingdom (966)  ·  Germany (856)  ·  Italy (811)  ·  Brazil (693)  ·  Puerto Rico (613)  ·  South Africa (600)  ·  Belgium (567)  ·  Turkey (Türkiye) (521)  ·  Australia (503)  ·  Thailand (424)

Top investigators

Anna Durbin, MD (30)

Results publications

PMID 34473343, PMID 35244208, PMID 31986264, PMID 35713300, PMID 32031570, PMID 32109013, PMID 32091533, PMID 32171076, PMID 34013969, PMID 36734509, PMID 37162745, PMID 33502773, PMID 36695483, PMID 30739368, PMID 32779730, PMID 34658014, PMID 37489818, PMID 37591523, PMID 40190112, PMID 25820067, PMID 30977945, PMID 32167524, PMID 39324693, PMID 40099800, PMID 30012435, PMID 30923816, PMID 34350582, PMID 28193518, PMID 29461687, PMID 31568620, PMID 32192578, PMID 32250385, PMID 30529905, PMID 32007143, PMID 32105632, PMID 32142651, PMID 33044747, PMID 33757717, PMID 38597249, PMID 29377566, PMID 29404492, PMID 33306989, PMID 33570583, PMID 36435633, PMID 24326304, PMID 25445400, PMID 30868245, PMID 32020029, PMID 32085846, PMID 32205204

NIH funding

2014 (71), 2015 (68), 2009 (63), 2008 (45), 2023 (43), 2016 (40), 2019 (34), 2018 (30), U01AI068636 (25), U01CA121947 (25), 2017 (22), 2025 (22), 2005 (21), U19AI057229 (21), UM1CA121947 (19)